Patients with low back pain are more likely to have surgery if they live in an area with more magnetic resonance imaging (MRI) machines, researchers say.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — The FDA recommended patients dispose of unused or expired medications today in a detailed list of disposal tips.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — Congress should limit the proposed period of market exclusivity for brand-name biologics to five years, rather than the 12 years in pending legislation, a prominent patent attorney and group of Harvard researchers said.
No Comments »
Filed under: General Health News
WASHINGTON (MedPage Today) — An FDA advisory panel has voted to recommend approval of an investigational drug to increase walking speed in patients with multiple sclerosis, despite an increased risk of seizures.
No Comments »
Filed under: Pharmacy News
WASHINGTON (MedPage Today) — The FDA recommended patients dispose of unused or expired medications today in a detailed list of disposal tips.
No Comments »
Filed under: Pharmacy News
WASHINGTON (MedPage Today) — Congress should limit the proposed period of market exclusivity for brand-name biologics to five years, rather than the 12 years in pending legislation, a prominent patent attorney and group of Harvard researchers said.
No Comments »
Filed under: Pharmacy News
Celsion Corporation announced today that it has received official approval from China’s State Food and Drug Administration (“SFDA”) for its Clinical Trial Application for ThermoDox that permits Celsion to include Chinese clinical trial sites in its Phase III ThermoDox HEAT trial for the treatment of primary liver cancer, also known as hepatocellular carcinoma (HCC).
No Comments »
Filed under: Pharmacy News
Soligenix, Inc., formerly known as DOR BioPharma, Inc., a late-stage biotechnology company, announced today that it has initiated enrollment in its confirmatory Phase 3 randomized, double-blind, placebo-controlled, multicenter clinical trial evaluating orBec(®) for the treatment of acute gastrointestinal Graft-versus-Host disease (GI GVHD).
No Comments »
Filed under: Pharmacy News
Inspire Pharmaceuticals, Inc. announced today Inspire scientists and collaborators will present data from the denufosol tetrasodium cystic fibrosis (CF) program in a poster presentation at the 23rd Annual North American Cystic Fibrosis Conference (NACFC) October 15 - 17, 2009 in Minneapolis, MN.
No Comments »
Filed under: Pharmacy News
Protalix BioTherapeutics, Inc., announced today positive top-line results from the Company’s pivotal Phase III clinical trial of UPLYSO (taliglucerase alfa, previously referred to as prGCD) in treatment naive patients diagnosed with Gaucher disease.
No Comments »
Filed under: Pharmacy News
